LDK378 in Adult Chinese Patients With ALK-rearranged (ALK-positive) Advanced Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Effect of a Single Infusion of VAY736 on Disease Activity in Patients With Relapsing-remitting Multiple Sclerosis
- Status
- TERMINATED
- Phase
- PHASE2
Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy.
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment Phase
- Status
- TERMINATED
- Phase
- PHASE3
Safety and Efficacy of BAF312 in Dermatomyositis
- Status
- TERMINATED
- Phase
- PHASE2
Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy
- Status
- COMPLETED
- Phase
- PHASE2
Predicting the Clinical Response to Omalizumab With Anti-Immunoglobulin E (IgE) Ab Response or Syk Expression in Basophils
- Status
- COMPLETED
- Phase
- PHASE4
Study to Collect and Assess Long-term Safety of Everolimus in Patients Who Are on Everolimus Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator.
- Status
- COMPLETED
- Phase
- PHASE2
Tobramycin Inhalation Powder (TIP) Administered Once Daily Continuously Versus TIP Administered BID in 28 Day on / 28 Day Off Cycles
- Status
- TERMINATED
- Phase
- PHASE4
Safety and Efficacy Study of Pazopanib and MK 3475 in Advanced Renal Cell Carcinoma (RCC; KEYNOTE-018)
- Status
- COMPLETED
- Phase
- PHASE1
16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients
- Status
- COMPLETED
- Phase
- PHASE3
Palmoplantar Pustular Psoriasis Efficacy and Safety With Secukinumab
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy, Safety and Tolerability of Sexelaxin When Added to Standard Therapy in AHF
- Status
- TERMINATED
- Phase
- PHASE3
Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and Glimepiride
- Status
- COMPLETED
- Phase
- PHASE4
ACZ885 for the Treatment of Abdominal Aortic Aneurysm
- Status
- TERMINATED
- Phase
- PHASE2
A Prospective, Observational, Multicentre, 2 Year Study Evaluating the Use of Eylea (Aflibercept) for the Treatment of Neovascular (Wet) Age-related Macular Degeneration in UK NHS Opthalmology Clinics
- Status
- TERMINATED
- Phase
- N/A